Antiprotozoal drugs: challenges and opportunities
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 11, 2023 Category: Drugs & Pharmacology Authors: Claudiu T. Supuran Source Type: research

A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 10, 2023 Category: Drugs & Pharmacology Authors: Mark éta Kovalová Joseph Peter Baraka V áclav Mik Radek Jorda Lei Luo Hao Shao Vladim ír Kryštof Source Type: research

Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 28, 2023 Category: Drugs & Pharmacology Authors: Lijuan Xu Wannian Zhang Chunlin Zhuang Source Type: research

Malaria vaccines
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 28, 2023 Category: Drugs & Pharmacology Authors: Michael Quagliata Anna Maria Papini Paolo Rovero Source Type: research

Current status and patent prospective of lipid nanoparticle for mRNA delivery
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 28, 2023 Category: Drugs & Pharmacology Authors: Hai-Long Zhang Source Type: research

Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 27, 2023 Category: Drugs & Pharmacology Authors: Nicola Salvatore Orefice Rossella Di Raimo Davide Mizzoni Mariantonia Logozzi Stefano Fais Source Type: research

Emerging compounds and therapeutic strategies to treat infections from Trypanosoma brucei: an overhaul of the last 5-years patents
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 27, 2023 Category: Drugs & Pharmacology Authors: Francesco Melfi Simone Carradori Cristina Campestre Entela Haloci Alessandra Ammazzalorso Rossella Grande Ilaria D ’Agostino Source Type: research

Evolution of pediatric pharmaceutical forms for treatment of Hansen ’s disease (leprosy)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 18, 2023 Category: Drugs & Pharmacology Authors: Jocimar da Silva Santos Franciely da Costa Alves Efraim Jos é Dos Santos Júnior Jos é Lamartine Soares Sobrinho M ônica Felts de La Roca Soares Source Type: research

An updated patent review of Nrf2 activators (2020-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 18, 2023 Category: Drugs & Pharmacology Authors: Ziquan Zhao Ruitian Dong Keni Cui Qidong You Zhengyu Jiang Source Type: research

Are patents important indicators of innovation for Chagas disease treatment?
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 15, 2023 Category: Drugs & Pharmacology Authors: Andrea Pestana Caroli Felipe R. P. Mansoldo Veronica S. Cardoso Celso Luiz Salgueiro Lage Flavia L. Carmo Claudiu T Supuran Alane Beatriz Vermelho Source Type: research

New designs for HIV-1 integrase inhibitors: a patent review (2018-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 14, 2023 Category: Drugs & Pharmacology Authors: Yoshiyuki Taoda Shuichi Sugiyama Takahiro Seki Source Type: research

An updated patent review of glutaminase inhibitors (2019 –2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 2, 2023 Category: Drugs & Pharmacology Authors: Danni Wang Xiaohong Li Guangyue Gong Yulong Lu Ziming Guo Rui Chen Huidan Huang Zhiyu Li Jinlei Bian Source Type: research

SUMO-specific protease 1 inhibitors –A literature and patent overview
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 31, 2023 Category: Drugs & Pharmacology Authors: Hang Li Leyuan Chen Yiliang Li Wenbin Hou Source Type: research

Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 20, 2023 Category: Drugs & Pharmacology Authors: Xiaoyu Shi Tong Zhao Edeildo Ferreira da Silva-J únior Jian Zhang Shujing Xu Peng Zhan Shenghua Gao Xinyong Liu Source Type: research

Inhibitors of cell cycle checkpoint target Wee1 kinase – a patent review (2003–2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 19, 2023 Category: Drugs & Pharmacology Authors: Jingxue Yan Lili Zhuang Yong Wang Yiqing Jiang Zhenlin Tu Chao Dong Yadong Chen Yong Zhu Source Type: research